409 related articles for article (PubMed ID: 23276981)
1. Gene delivery with viral vectors for cerebrovascular diseases.
Gan Y; Jing Z; Stetler RA; Cao G
Front Biosci (Elite Ed); 2013 Jan; 5(1):188-203. PubMed ID: 23276981
[TBL] [Abstract][Full Text] [Related]
2. Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors.
Puhl DL; D'Amato AR; Gilbert RJ
Brain Res Bull; 2019 Aug; 150():216-230. PubMed ID: 31173859
[TBL] [Abstract][Full Text] [Related]
3. Viral vectors for gene transfer: a review of their use in the treatment of human diseases.
Walther W; Stein U
Drugs; 2000 Aug; 60(2):249-71. PubMed ID: 10983732
[TBL] [Abstract][Full Text] [Related]
4. Introduction to Viral Vectors and Other Delivery Methods for Gene Therapy of the Nervous System.
Manfredsson FP
Methods Mol Biol; 2016; 1382():3-18. PubMed ID: 26611575
[TBL] [Abstract][Full Text] [Related]
5. Progresses towards safe and efficient gene therapy vectors.
Chira S; Jackson CS; Oprea I; Ozturk F; Pepper MS; Diaconu I; Braicu C; Raduly LZ; Calin GA; Berindan-Neagoe I
Oncotarget; 2015 Oct; 6(31):30675-703. PubMed ID: 26362400
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy in cerebrovascular diseases.
Gabriel RA; Yang GY
Curr Gene Ther; 2007 Dec; 7(6):421-33. PubMed ID: 18045102
[TBL] [Abstract][Full Text] [Related]
7. Viral vectors for gene delivery to the central nervous system.
Lentz TB; Gray SJ; Samulski RJ
Neurobiol Dis; 2012 Nov; 48(2):179-88. PubMed ID: 22001604
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain.
Serguera C; Bemelmans AP
Rev Neurol (Paris); 2014 Dec; 170(12):727-38. PubMed ID: 25459120
[TBL] [Abstract][Full Text] [Related]
9. Methods for gene transfer to the central nervous system.
Kantor B; Bailey RM; Wimberly K; Kalburgi SN; Gray SJ
Adv Genet; 2014; 87():125-97. PubMed ID: 25311922
[TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications.
Wong LF; Goodhead L; Prat C; Mitrophanous KA; Kingsman SM; Mazarakis ND
Hum Gene Ther; 2006 Jan; 17(1):1-9. PubMed ID: 16409120
[TBL] [Abstract][Full Text] [Related]
11. Viral Vector-Based Gene Therapy.
Li X; Le Y; Zhang Z; Nian X; Liu B; Yang X
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175441
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy and neurodevelopmental disorders.
Gray SJ
Neuropharmacology; 2013 May; 68():136-42. PubMed ID: 22750077
[TBL] [Abstract][Full Text] [Related]
13. Liposomal and viral vectors for gene therapy of the central nervous system.
de Lima MC; da Cruz MT; Cardoso AL; Simoes S; de Almeida LP
Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):453-65. PubMed ID: 16101560
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system.
Ruitenberg MJ; Eggers R; Boer GJ; Verhaagen J
Methods; 2002 Oct; 28(2):182-94. PubMed ID: 12413416
[TBL] [Abstract][Full Text] [Related]
15. Invasive drug delivery.
Blömer U; Ganser A; Scherr M
Adv Exp Med Biol; 2002; 513():431-51. PubMed ID: 12575831
[TBL] [Abstract][Full Text] [Related]
16. Viral vectors for gene delivery and gene therapy within the endocrine system.
Stone D; David A; Bolognani F; Lowenstein PR; Castro MG
J Endocrinol; 2000 Feb; 164(2):103-18. PubMed ID: 10657846
[TBL] [Abstract][Full Text] [Related]
17. A Review of Gene Therapy Delivery Systems for Intervertebral Disc Degeneration.
Chen S; Luo M; Kou H; Shang G; Ji Y; Liu H
Curr Pharm Biotechnol; 2020; 21(3):194-205. PubMed ID: 31749423
[TBL] [Abstract][Full Text] [Related]
18. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model.
Björklund A; Kirik D; Rosenblad C; Georgievska B; Lundberg C; Mandel RJ
Brain Res; 2000 Dec; 886(1-2):82-98. PubMed ID: 11119690
[TBL] [Abstract][Full Text] [Related]
19. AAV as a gene transfer vector for the treatment of neurological disorders: novel treatment thoughts for ALS.
Hester ME; Foust KD; Kaspar RW; Kaspar BK
Curr Gene Ther; 2009 Oct; 9(5):428-33. PubMed ID: 19860657
[TBL] [Abstract][Full Text] [Related]
20. Viral Vector Delivery of DREADDs for CNS Therapy.
Pickering CA; Mazarakis ND
Curr Gene Ther; 2021; 21(3):191-206. PubMed ID: 33573551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
